Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LISA MASINTER

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Obstetrics

NPI
1194984575
CMS profile
1251093
Location
CHICAGO, IL

General Payments · PY2019–2022

$57,840.82

  • Reported across 54 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$18,167.35

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $18,167.35 16

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $18,167.35 16

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,599.68 8
PY2020 $11,471.10 12
PY2021 $21,602.69 18
PY2022 $18,167.35 16

Payment records · PY2022 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2022 201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Merck Sharp & Dohme LLC $1,207.41 01/15/2022 Consulting Fee Undisputed 01/23/2026 944042893 CMS
Merck Sharp & Dohme LLC $1,207.41 01/31/2022 Consulting Fee Undisputed 01/23/2026 944042898 CMS
Merck Sharp & Dohme LLC $1,183.89 02/15/2022 Consulting Fee Undisputed 01/23/2026 944310009 CMS
Merck Sharp & Dohme LLC $1,183.89 02/28/2022 Consulting Fee Undisputed 01/23/2026 944042887 CMS
Merck Sharp & Dohme LLC $1,176.05 03/15/2022 Consulting Fee Undisputed 01/23/2026 944042877 CMS
Merck Sharp & Dohme LLC $1,176.05 03/31/2022 Consulting Fee Undisputed 01/23/2026 944042883 CMS
Merck Sharp & Dohme LLC $1,176.05 04/15/2022 Consulting Fee Undisputed 01/23/2026 944040585 CMS
Merck Sharp & Dohme LLC $1,176.05 04/30/2022 Consulting Fee Undisputed 01/23/2026 944040589 CMS
Merck Sharp & Dohme LLC $1,215.25 05/15/2022 Consulting Fee Undisputed 01/23/2026 944040591 CMS
Merck Sharp & Dohme LLC $1,215.26 05/31/2022 Consulting Fee Undisputed 01/23/2026 944040595 CMS
Merck Sharp & Dohme LLC $1,246.61 06/15/2022 Consulting Fee Undisputed 01/23/2026 944040597 CMS
Merck Sharp & Dohme LLC $1,246.61 06/30/2022 Consulting Fee Undisputed 01/23/2026 944307619 CMS
Merck Sharp & Dohme LLC $1,160.37 07/15/2022 Consulting Fee Undisputed 01/23/2026 944051867 CMS
Merck Sharp & Dohme LLC $1,160.37 07/31/2022 Consulting Fee Undisputed 01/23/2026 944051873 CMS
Merck Sharp & Dohme LLC $718.04 08/15/2022 Consulting Fee Undisputed 01/23/2026 944051877 CMS
Merck Sharp & Dohme LLC $718.04 08/31/2022 Consulting Fee Undisputed 01/23/2026 944051883 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.